Patents by Inventor Andrew Morse
Andrew Morse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20100009983Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a 5HTR agent, in combination with one or more other neurogenic agents, or anti-astrogenic agent, to stimulate or activate the formation of new nerve cells.Type: ApplicationFiled: June 25, 2009Publication date: January 14, 2010Applicant: BrainCells, Inc.Inventors: Carrolee Barlow, Todd A. Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
-
Publication number: 20090325949Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a 5HTR agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.Type: ApplicationFiled: June 25, 2009Publication date: December 31, 2009Applicant: BrainCells, Inc.Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
-
Publication number: 20090239834Abstract: The disclosure provides methods and a composition for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis by use of (5-acetamido-N-(5alpha-cholestan-3alpha-yl)-3,5-dideoxy-2-O-methyl-D-glycero-alpha-D-galacto-non-2-ulopyranosonamide(MCC-257).Type: ApplicationFiled: March 23, 2009Publication date: September 24, 2009Applicant: BrainCells, Inc.Inventors: Carrolee Barlow, Todd A. Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
-
Publication number: 20090197823Abstract: The disclosure provides compositions and methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis by use of a renin inhibitor in combination with one or more neurogenic agents. The disclosure also includes compositions and methods for stimulating or activating the formation of new nerve cells based on the application of a renin inhibitor in combination with one or more neurogenic agents.Type: ApplicationFiled: March 23, 2009Publication date: August 6, 2009Applicant: BrainCells, Inc.Inventors: Carrolee Barlow, Todd A. Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
-
Publication number: 20080188457Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of one or more biguanides in combination with one or more GSK3-? agents, to stimulate or activate the formation of new nerve cells.Type: ApplicationFiled: February 1, 2008Publication date: August 7, 2008Applicant: BrainCells, Inc.Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
-
Publication number: 20080171750Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of modafinil, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.Type: ApplicationFiled: January 10, 2008Publication date: July 17, 2008Applicant: BrainCells, Inc.Inventors: Carrolee Barlow, Todd A. Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
-
Publication number: 20080167363Abstract: The present disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of melatonin or other melatoninergic agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.Type: ApplicationFiled: December 27, 2007Publication date: July 10, 2008Applicant: BrainCells, IncInventors: Carrolee Barlow, Todd A. Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain, Jeff Redwine, Christine Hoffmaster
-
Publication number: 20080108574Abstract: The present disclosure describes compositions and methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a melanocortin receptor (MCR) modulating agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.Type: ApplicationFiled: September 26, 2007Publication date: May 8, 2008Applicant: BrainCells, Inc.Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym Lorrain
-
Publication number: 20080103165Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system including by stimulating or increasing neurogenesis, neuroproliferation, and/or neurodifferentiation. The disclosure includes compositions and methods based on use of a peroxisome proliferator-activated receptor (PPAR) agent, optionally in combination with one or more other neurogenic agents, to stimulate or increase a neurogenic response and/or to treat a disease.Type: ApplicationFiled: September 18, 2007Publication date: May 1, 2008Applicant: BrainCells, Inc.Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym Lorrain
-
Publication number: 20080103105Abstract: The instant disclosure describes methods of treating diseases and conditions of the central and peripheral nervous system including by stimulating or increasing neurogenesis, neuroproliferation, and/or neurodifferentiation. The disclosure includes compositions and methods based on use of an HMGCR modulating agent, optionally in combination with one or more other neurogenic agents, to stimulate or increase a neurogenic response and/or to treat disease.Type: ApplicationFiled: September 20, 2007Publication date: May 1, 2008Applicant: BrainCells, Inc.Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym Lorrain, Jeff Redwine, Christine Hoffmaster
-
Publication number: 20080085885Abstract: The present invention relates to methods of inhibiting or reducing voluntary alcohol consumption in a subject comprising administering a non-peptidyl melanocortin 4 receptor agonist to said subject. The present invention further relates to methods of treating or preventing alcoholism, alcohol abuse, and alcohol related disorders in a subject comprising administering a non-peptidyl melanocortin 4 receptor agonist to said subject. The present invention further provides for pharmaceutical compositions and medicaments useful in carrying out these methods.Type: ApplicationFiled: August 9, 2005Publication date: April 10, 2008Inventors: Linda Bristow, Tung Fong, Andrew Morse, Kunkun Ren
-
Publication number: 20080064671Abstract: The instant disclosure describes compositions and methods for treating diseases and conditions of the central and peripheral nervous system. The disclosure includes compositions and methods based on use of a 4-acylaminopyridine derivative in combination with one or more other neurogenic agents. One 4-acylaminopyridine derivative is MKC-231.Type: ApplicationFiled: June 21, 2007Publication date: March 13, 2008Applicant: BrainCells, Inc.Inventors: Carrolee Barlow, Todd A. Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
-
Publication number: 20080021067Abstract: The present invention relates to methods of treating and preventing substance addiction and substance abuse, including nicotine addiction and nicotine addiction-related disorders in a subject comprising administering a melanocortin 4 receptor agonist to said subject. The present invention further relates to methods of treating or preventing substance addiction and substance addiction-related disorders in a subject comprising administering a melanocortin 4 receptor agonist to said subject. The present invention further provides for pharmaceutical compositions and medicaments useful in carrying out these methods.Type: ApplicationFiled: September 30, 2005Publication date: January 24, 2008Inventors: Linda Bristow, Tung Fong, Andrew Morse
-
Publication number: 20070270449Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a 5HTR agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.Type: ApplicationFiled: May 8, 2007Publication date: November 22, 2007Applicant: BrainCells, Inc.Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym Lorrain
-
Publication number: 20070244143Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of melatonin or other nootropic agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.Type: ApplicationFiled: March 8, 2007Publication date: October 18, 2007Applicant: BrainCells, IncInventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym Lorrain, Dana Gitnick, Jammieson Pires
-
Publication number: 20070112017Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a GABA agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.Type: ApplicationFiled: October 30, 2006Publication date: May 17, 2007Applicant: BrainCells, Inc.Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kym Lorrain, Jammieson Pires, Kai Treuner
-
Publication number: 20070078083Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on an HDac inhibitory agent alone or in combination with another neurogenic agent to stimulate or activate the formation of new nerve cells.Type: ApplicationFiled: September 7, 2006Publication date: April 5, 2007Applicant: BrainCells, Inc.Inventors: Carrolee Barlow, Todd Carter, Kym Lorrain, Jammieson Pires, Andrew Morse, Dana Gitnick, Kai Treuner, Alejandro Dearie
-
Publication number: 20070049576Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on muscarinic receptor modulation, such as via inhibition of acetylcholine esterase (AChE) activity, alone or in combination with another neurogenic agent to stimulate or activate the formation of new nerve cells.Type: ApplicationFiled: August 25, 2006Publication date: March 1, 2007Applicant: BrainCells, Inc.Inventors: Carrolee Barlow, Tood Carter, Kym Lorrain, Jammieson Pires, Andrew Morse, Dana Gitnick, Kai Treuner, Alex Broadhead
-
Patent number: 5061540Abstract: A strip of fastener material adapted for securing to the surface of a foam bun during molding, carries on a first surface an area of outwardly extending elements constituting one half of a touch fastening system. The first surface is arranged to be positioned so that it faces into a trough in a mold wall and this first surface is provided with a pair of elongated flexible sealing lips adjacent the edges of the area. Magnetizable means are also carried by the strip and the fastener strip has portions extending laterally beyond the sealing lips and beyond the edges of the trough in the mold wall.Type: GrantFiled: January 25, 1990Date of Patent: October 29, 1991Assignee: Velcro Industries B.V.Inventors: Humphrey Cripps, Gerald F. Rocha, Andrew Morse, William J. Kennedy
-
Patent number: 4669958Abstract: A swashplate control system (10) has a first gimbal ring (26) pivotally mounted at (32) along a longitudinal axis. A second gimbal ring (24) is pivotally attached at (28) to the first gimbal ring (26) along a lateral axis. A longitudinal cyclic actuator (14) pivots the first gimbal ring (26) along the longitudinal axis. A lateral cyclic actuator (16) pivots the second gimbal ring (24) along the lateral axis. The lateral cyclic actuator (16) is mounted on the first gimbal ring (26). A swashplate (12) is rotatably mounted on the second gimbal ring (24).Type: GrantFiled: March 31, 1986Date of Patent: June 2, 1987Assignee: The United States of America as represented by the Administrator of the National Aeronautics and Space AdministrationInventors: Richard J. Peyran, Georgene H. Laub, H. Andrew Morse